Szent Borbala Korhaz
About Szent Borbala Korhaz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Amgen
4
St. Borbala Hospital
3
Arena Pharmaceuticals
2
Celgene
2
Pfizer
2
Sierra Oncology, Inc.
2
Apollomics Inc.
1
Bayer
1
BioNTech SE
1
Daiichi Sankyo, Inc.
1
Clinical Trials at Szent Borbala Korhaz
During the past decade, Szent Borbala Korhaz conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 9 clinical trials were completed, i.e. on
average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 6 clinical trials were completed. i.e. 31.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
2008-01-01
2010-06-24
Completed
201
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
2009-01-27
2020-10-27
Completed
317
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
2009-10-13
2018-05-09
Completed
450
Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer
2012-04-01
2016-07-01
Terminated
222
A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments
2011-11-01
2015-06-27
Completed
135
An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer
2011-07-01
2014-12-01
Completed
882
An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic Leukemia
2014-06-24
2016-12-19
Completed
150
An Observational Study of Continued Bevacizumab Plus Chemotherapy Until First Progression in Participants With Metastatic Colorectal Cancer (CRC)
2015-01-13
2017-12-29
Completed
300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Szent Borbala Korhaz" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Amgen" with 4 trials
sponsored, "St. Borbala Hospital" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Celgene"
with 2 trials sponsored. Other sponsors include 16 different institutions and
companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Szent Borbala Korhaz"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Biological Research Centre, Szeged" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Department of Surgery, Bács-Kiskun Megyei Kórház, Kecskemét" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at Szent Borbala Korhaz
According to Clinical.Site data, the most researched conditions in "Szent Borbala Korhaz" are
"Colorectal Cancer" (4 trials), "Ulcerative Colitis" (4 trials), "Gastric Cancer" (2 trials), "Gastroesophageal Junction Adenocarcinoma" (2 trials) and "Idiopathic Pulmonary Fibrosis" (2 trials). Many other conditions were trialed in "Szent Borbala Korhaz" in a lesser frequency.
Clinical Trials Intervention Types at Szent Borbala Korhaz
Most popular intervention types in "Szent Borbala Korhaz" are "Drug" (34 trials), "Biological" (5 trials), "Other" (4 trials), "Combination Product" (2 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Etrasimod" (4 trials), "Docetaxel" (3 trials), "Chemotherapy" (2 trials) and "Lenalidomide" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Szent Borbala Korhaz
The vast majority of trials in "Szent Borbala Korhaz" are
37 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Szent Borbala Korhaz
Currently, there are NaN active trials in "Szent Borbala Korhaz".
undefined are not yet recruiting,
14 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Szent Borbala Korhaz,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Szent Borbala Korhaz, 3 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 25 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".